Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

Heleen J. Bouman; Ankie M. Harmsze; Jochem W. van Werkum; Nicoline J. Breet; Th O. Bergmeijer; Hugo ten Cate; Christian M. Hackeng; Vera H. M. Deneer; Jurrien M Ten Berg

doi:10.1136/hrt.2010.220509

Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

Heleen J. Bouman, Ankie M. Harmsze, Jochem W. van Werkum, Nicoline J. Breet, Th O. Bergmeijer, Hugo ten Cate, Christian M. Hackeng, Vera H. M. Deneer, Jurrien M Ten Berg

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1239-1244
Journal	Heart
Volume	97
Issue number	15
DOIs	https://doi.org/10.1136/hrt.2010.220509
Publication status	Published - Aug 2011

Access to Document

10.1136/hrt.2010.220509

Cite this

Bouman, H. J., Harmsze, A. M., van Werkum, J. W., Breet, N. J., Bergmeijer, T. O., ten Cate, H., Hackeng, C. M., Deneer, V. H. M., & Ten Berg, J. M. (2011). Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting. Heart, 97(15), 1239-1244. https://doi.org/10.1136/hrt.2010.220509

Bouman, Heleen J. ; Harmsze, Ankie M. ; van Werkum, Jochem W. ; Breet, Nicoline J. ; Bergmeijer, Th O. ; ten Cate, Hugo ; Hackeng, Christian M. ; Deneer, Vera H. M. ; Ten Berg, Jurrien M. / Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting. In: Heart. 2011 ; Vol. 97, No. 15. pp. 1239-1244.

@article{3b4874febce743f5b988705022b49107,

title = "Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting",

author = "Bouman, {Heleen J.} and Harmsze, {Ankie M.} and {van Werkum}, {Jochem W.} and Breet, {Nicoline J.} and Bergmeijer, {Th O.} and {ten Cate}, Hugo and Hackeng, {Christian M.} and Deneer, {Vera H. M.} and {Ten Berg}, {Jurrien M}",

year = "2011",

month = aug,

doi = "10.1136/hrt.2010.220509",

language = "English",

volume = "97",

pages = "1239--1244",

journal = "Heart",

issn = "1355-6037",

publisher = "BMJ Publishing Group",

number = "15",

}

Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting. / Bouman, Heleen J.; Harmsze, Ankie M.; van Werkum, Jochem W.; Breet, Nicoline J.; Bergmeijer, Th O.; ten Cate, Hugo; Hackeng, Christian M.; Deneer, Vera H. M.; Ten Berg, Jurrien M.

In: Heart, Vol. 97, No. 15, 08.2011, p. 1239-1244.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting

AU - Bouman, Heleen J.

AU - Harmsze, Ankie M.

AU - van Werkum, Jochem W.

AU - Breet, Nicoline J.

AU - Bergmeijer, Th O.

AU - ten Cate, Hugo

AU - Hackeng, Christian M.

AU - Deneer, Vera H. M.

AU - Ten Berg, Jurrien M

PY - 2011/8

Y1 - 2011/8

U2 - 10.1136/hrt.2010.220509

DO - 10.1136/hrt.2010.220509

M3 - Article

VL - 97

SP - 1239

EP - 1244

JO - Heart

JF - Heart

SN - 1355-6037

IS - 15

ER -